SEC Form 3 · accession 0001662252-17-000078
Rich Pharmaceuticals, Inc. · RCHA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carole A. Salvador
Director
Period of report
Mar 30, 2017
Accepted (ET)
Apr 6, 2017 · 12:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504389
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $0.0001 | holding | — | — | — | Mar 30, 2017 | Mar 29, 2022 | Common Stock | 70,000,000 | — | D |
Explanation of responses
- F1On March 30, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2017 Stock Option / Stock Issuance Plan (the "Plan"). The Reporting Owner has the right to 70,000,000 shares of common stock of the Issuer under the Plan at an exercise price of $0.0001. The Option vests immediately, has a 5 year term and may be exercised by cashless exercise.